Search Count: 40
 |
Insulin-Regulated Aminopeptidase Complexed With A Macrocyclic Peptidic Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2020-07-22 Classification: HYDROLASE Ligands: ONN, ZN, NAG, SIN, EDO, PGE, PG4, PO4, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-22
Ligands: ONN, ZN, NAG, SIN, EDO, PGE, PG4, PO4, PEG
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 9MW |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 9MW
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 378 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 378
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 1T8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 1T8
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 1T8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 1T8
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, V78 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, V78
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, V78 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, V78
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, J3W |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, J3W
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, M17 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-10
Ligands: CL, M17
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, 9MW |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-10
Ligands: CL, 9MW
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, EQM |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, EQM
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, M8Y |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, M8Y
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, M8B |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, M8B
 |
Structure Of Mycobacterium Tuberculosis Dxr In Complex With A Fosmidomycin Analogue
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2013-10-09 Classification: OXIDOREDUCTASE Ligands: MN, FM6 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2013-10-09
Ligands: MN, FM6
 |
Structure Of Mycobacterium Tuberculosis Dxr In Complex With A Di- Substituted Fosmidomycin Analogue
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2013-10-09 Classification: OXIDOREDUCTASE Ligands: MN, FM6, NDP |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2013-10-09
Ligands: MN, FM6, NDP
 |
Structure Of Mycobacterium Tuberculosis Dxr In Complex With A Fosmidomycin Analogue
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2013-10-09 Classification: OXIDOREDUCTASE Ligands: FM7 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2013-10-09
Ligands: FM7
 |
Structure Of Mycobacterium Tuberculosis Dxr In Complex With A Fosmidomycin Analogue
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-10-09 Classification: OXIDOREDUCTASE Ligands: FM8, MN |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2013-10-09
Ligands: FM8, MN
 |
Stereoselective Synthesis, X-Ray Analysis, And Biological Evaluation Of A New Class Of Lactam Based Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-11-07 Classification: HYDROLASE Ligands: UX9 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2012-11-07
Ligands: UX9
 |
Crystal Structure Of Mycobacterium Tuberculosis Glutamine Synthetase In Complex With Imidazopyridine Inhibitor ((4-(6-Bromo-3-(Butylamino)Imidazo(1,2-A)Pyridin-2-Yl)Phenoxy) Acetic Acid) And L-Methionine-S-Sulfoximine Phosphate.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2012-10-24 Classification: LIGASE Ligands: 46B, MG, P3S, PO4, CL |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2012-10-24
Ligands: 46B, MG, P3S, PO4, CL
 |
Stereoselective Synthesis, X-Ray Analysis, And Biological Evaluation Of A New Class Of Lactam Based Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-05-09 Classification: HYDROLASE Ligands: QG8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2012-05-09
Ligands: QG8